Court Rules for GlaxoSmithKline in USPTO Rulemaking Case
 
The US District for the Eastern District of Virginia has granted summary judgment to GlaxoSmithKline and Tafas, ruling in support of GSK’s challenge to final rules issued by the US Patent and Trademark Office in August, the pharma giant said this week.
 
GSK said that the court essentially decided that the proposed rules are substantive in nature, and that the PTO has exceeded its rulemaking authority under the law.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.